TreeWAS – Variant ID: rs77292326

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R10.1 Pain localised to upper abdomen	0.354	0.646	0.000
B37.0 Candidal stomatitis	0.000	0.879	0.121
B37 Candidiasis	0.000	0.882	0.118
B37.8 Candidiasis of other sites	0.000	0.884	0.116
B37.9 Candidiasis, unspecified	0.000	0.900	0.100
B37.3 Candidiasis of vulva and vagina	0.000	0.908	0.092
B37.7 Candidal septicaemia	0.000	0.915	0.085
B37.6 Candidal endocarditis	0.000	0.915	0.085
B37.5 Candidal meningitis	0.000	0.915	0.085
B37.4 Candidiasis of other urogenital sites	0.000	0.915	0.085
B37.2 Candidiasis of skin and nail	0.000	0.915	0.085
B37.1 Pulmonary candidiasis	0.000	0.915	0.085
B35-B49 Mycoses	0.000	0.940	0.060
B35 Dermatophytosis	0.000	0.950	0.050
B48 Other mycoses, not elsewhere classified	0.000	0.957	0.043
B47 Mycetoma	0.000	0.957	0.043
B46 Zygomycosis	0.000	0.957	0.043
B45 Cryptococcosis	0.000	0.957	0.043
B43 Chromomycosis and phaeomycotic abscess	0.000	0.957	0.043
B42 Sporotrichosis	0.000	0.957	0.043
B41 Paracoccidioidomycosis	0.000	0.957	0.043
B40 Blastomycosis	0.000	0.957	0.043
B39 Histoplasmosis	0.000	0.957	0.043
B38 Coccidioidomycosis	0.000	0.957	0.043
B36 Other superficial mycoses	0.000	0.957	0.043
B35.3 Tinea pedis	0.000	0.957	0.043
B44 Aspergillosis	0.000	0.958	0.042
B49 Unspecified mycosis	0.000	0.959	0.041
B35.9 Dermatophytosis, unspecified	0.000	0.964	0.036
B35.8 Other dermatophytoses	0.000	0.964	0.036
B35.6 Tinea cruris	0.000	0.964	0.036
B35.5 Tinea imbricata	0.000	0.964	0.036
B35.4 Tinea corporis	0.000	0.964	0.036
B35.2 Tinea manuum	0.000	0.964	0.036
B35.1 Tinea unguium	0.000	0.964	0.036
B35.0 Tinea barbae and tinea capitis	0.000	0.964	0.036
B36.9 Superficial mycosis, unspecified	0.000	0.969	0.031
B36.8 Other specified superficial mycoses	0.000	0.969	0.031
B36.3 Black piedra	0.000	0.969	0.031
B36.2 White piedra	0.000	0.969	0.031
B36.1 Tinea nigra	0.000	0.969	0.031
B36.0 Pityriasis versicolor	0.000	0.969	0.031
B38.9 Coccidioidomycosis, unspecified	0.000	0.969	0.031
B38.8 Other forms of coccidioidomycosis	0.000	0.969	0.031
B38.7 Disseminated coccidioidomycosis	0.000	0.969	0.031
B38.4 Coccidioidomycosis meningitis	0.000	0.969	0.031
B38.3 Cutaneous coccidioidomycosis	0.000	0.969	0.031
B38.2 Pulmonary coccidioidomycosis, unspecified	0.000	0.969	0.031
B38.1 Chronic pulmonary coccidioidomycosis	0.000	0.969	0.031
B38.0 Acute pulmonary coccidioidomycosis	0.000	0.969	0.031
B39.9 Histoplasmosis, unspecified	0.000	0.969	0.031
B39.5 Histoplasmosis duboisii	0.000	0.969	0.031
B39.4 Histoplasmosis capsulati, unspecified	0.000	0.969	0.031
B39.3 Disseminated histoplasmosis capsulati	0.000	0.969	0.031
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.000	0.969	0.031
B39.1 Chronic pulmonary histoplasmosis capsulati	0.000	0.969	0.031
B39.0 Acute pulmonary histoplasmosis capsulati	0.000	0.969	0.031
B40.9 Blastomycosis, unspecified	0.000	0.969	0.031
B40.8 Other forms of blastomycosis	0.000	0.969	0.031
B40.7 Disseminated blastomycosis	0.000	0.969	0.031
B40.3 Cutaneous blastomycosis	0.000	0.969	0.031
B40.2 Pulmonary blastomycosis, unspecified	0.000	0.969	0.031
B40.1 Chronic pulmonary blastomycosis	0.000	0.969	0.031
B40.0 Acute pulmonary blastomycosis	0.000	0.969	0.031
B41.9 Paracoccidioidomycosis, unspecified	0.000	0.969	0.031
B41.8 Other forms of paracoccidioidomycosis	0.000	0.969	0.031
B41.7 Disseminated paracoccidioidomycosis	0.000	0.969	0.031
B41.0 Pulmonary paracoccidioidomycosis	0.000	0.969	0.031
B42.9 Sporotrichosis, unspecified	0.000	0.969	0.031
B42.8 Other forms of sporotrichosis	0.000	0.969	0.031
B42.7 Disseminated sporotrichosis	0.000	0.969	0.031
B42.1 Lymphocutaneous sporotrichosis	0.000	0.969	0.031
B42.0 Pulmonary sporotrichosis	0.000	0.969	0.031
B43.9 Chromomycosis, unspecified	0.000	0.969	0.031
B43.8 Other forms of chromomycosis	0.000	0.969	0.031
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.000	0.969	0.031
B43.1 Phaeomycotic brain abscess	0.000	0.969	0.031
B43.0 Cutaneous chromomycosis	0.000	0.969	0.031
B45.9 Cryptococcosis, unspecified	0.000	0.969	0.031
B45.8 Other forms of cryptococcosis	0.000	0.969	0.031
B45.7 Disseminated cryptococcosis	0.000	0.969	0.031
B45.3 Osseous cryptococcosis	0.000	0.969	0.031
B45.2 Cutaneous cryptococcosis	0.000	0.969	0.031
B45.1 Cerebral cryptococcosis	0.000	0.969	0.031
B45.0 Pulmonary cryptococcosis	0.000	0.969	0.031
B46.9 Zygomycosis, unspecified	0.000	0.969	0.031
B46.8 Other zygomycoses	0.000	0.969	0.031
B46.5 Mucormycosis, unspecified	0.000	0.969	0.031
B46.4 Disseminated mucormycosis	0.000	0.969	0.031
B46.3 Cutaneous mucormycosis	0.000	0.969	0.031
B46.2 Gastro-intestinal mucormycosis	0.000	0.969	0.031
B46.1 Rhinocerebral mucormycosis	0.000	0.969	0.031
B46.0 Pulmonary mucormycosis	0.000	0.969	0.031
B47.9 Mycetoma, unspecified	0.000	0.969	0.031
B47.1 Actinomycetoma	0.000	0.969	0.031
B47.0 Eumycetoma	0.000	0.969	0.031
B48.8 Other specified mycoses	0.000	0.969	0.031
B48.7 Opportunistic mycoses	0.000	0.969	0.031
B48.4 Penicillosis	0.000	0.969	0.031
B48.3 Geotrichosis	0.000	0.969	0.031
B48.2 Allescheriasis	0.000	0.969	0.031
B48.1 Rhinosporidiosis	0.000	0.969	0.031
B48.0 Lobomycosis	0.000	0.969	0.031
B44.9 Aspergillosis, unspecified	0.000	0.969	0.031
B44.8 Other forms of aspergillosis	0.000	0.969	0.030
B44.7 Disseminated aspergillosis	0.000	0.969	0.030
B44.2 Tonsillar aspergillosis	0.000	0.969	0.030
B44.0 Invasive pulmonary aspergillosis	0.000	0.969	0.030
B44.1 Other pulmonary aspergillosis	0.000	0.971	0.029
R10 Abdominal and pelvic pain	0.027	0.973	0.000
R10.2 Pelvic and perineal pain	0.020	0.980	0.000
R10.0 Acute abdomen	0.017	0.983	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.015	0.985	0.000
G20 Parkinson's disease	0.015	0.985	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.989	0.011
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.989	0.011
R10.4 Other and unspecified abdominal pain	0.010	0.990	0.000
T39.1 4-Aminophenol derivatives	0.000	0.990	0.010
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.991	0.009
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.992	0.008
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.992	0.008
T40.2 Other opioids	0.000	0.992	0.008
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
M54.59 Low back pain (Site unspecified)	0.000	0.992	0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.992	0.008
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.992	0.008
T39.4 Antirheumatics, not elsewhere classified	0.000	0.992	0.008
T39.2 Pyrazolone derivatives	0.000	0.992	0.008
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.992	0.008
T39.0 Salicylates	0.000	0.992	0.008
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.993	0.007
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.993	0.007
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.993	0.007
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.993	0.007
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.993	0.007
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.993	0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.993	0.007
T36 Poisoning by systemic antibiotics	0.000	0.993	0.007
Z60.2 Living alone	0.000	0.993	0.007
H71 Cholesteatoma of middle ear	0.007	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.993	0.007
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.993	0.006
H65-H75 Diseases of middle ear and mastoid	0.007	0.993	0.000
T42.4 Benzodiazepines	0.000	0.993	0.006
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.994	0.006
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.994	0.006
T43.2 Other and unspecified antidepressants	0.000	0.994	0.006
H74 Other disorders of middle ear and mastoid	0.006	0.994	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.994	0.006
T40.8 Lysergide [LSD]	0.000	0.994	0.006
T40.7 Cannabis (derivatives)	0.000	0.994	0.006
T40.6 Other and unspecified narcotics	0.000	0.994	0.006
T40.5 Cocaine	0.000	0.994	0.006
T40.3 Methadone	0.000	0.994	0.006
T40.1 Heroin	0.000	0.994	0.006
T40.0 Opium	0.000	0.994	0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.994	0.006
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.994	0.006
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.994	0.006
T42.3 Barbiturates	0.000	0.994	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.994	0.006
T42.1 Iminostilbenes	0.000	0.994	0.006
T42.0 Hydantoin derivatives	0.000	0.994	0.006
T43.9 Psychotropic drug, unspecified	0.000	0.994	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.994	0.006
H65 Nonsuppurative otitis media	0.006	0.994	0.000
H72 Perforation of tympanic membrane	0.006	0.994	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
H65.9 Nonsuppurative otitis media, unspecified	0.006	0.994	0.000
T40.4 Other synthetic narcotics	0.000	0.994	0.006
H74.3 Other acquired abnormalities of ear ossicles	0.006	0.994	0.000
H66 Suppurative and unspecified otitis media	0.006	0.994	0.000
H74.4 Polyp of middle ear	0.005	0.994	0.000
T50.8 Diagnostic agents	0.000	0.994	0.005
T50.7 Analeptics and opioid receptor antagonists	0.000	0.994	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.994	0.005
T50.5 Appetite depressants	0.000	0.994	0.005
T50.4 Drugs affecting uric acid metabolism	0.000	0.994	0.005
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.994	0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.994	0.005
T50.1 Loop [high-ceiling] diuretics	0.000	0.994	0.005
T50.0 Mineralocorticoids and their antagonists	0.000	0.994	0.005
M54.5 Low back pain	0.000	0.995	0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.995	0.005
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.995	0.005
T46.7 Peripheral vasodilators	0.000	0.995	0.005
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.995	0.005
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.995	0.005
T46.1 Calcium-channel blockers	0.000	0.995	0.005
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.995	0.005
H74.9 Disorder of middle ear and mastoid, unspecified	0.005	0.995	0.000
Z90.4 Acquired absence of other parts of digestive tract	0.005	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.995	0.005
T36.8 Other systemic antibiotics	0.000	0.995	0.005
T36.7 Antifungal antibiotics, systemically used	0.000	0.995	0.005
T36.6 Rifamycins	0.000	0.995	0.005
T36.5 Aminoglycosides	0.000	0.995	0.005
T36.4 Tetracyclines	0.000	0.995	0.005
T36.3 Macrolides	0.000	0.995	0.005
T36.2 Chloramphenicol group	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.005
T36.0 Penicillins	0.000	0.995	0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.995	0.005
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.995	0.005
T37.5 Antiviral drugs	0.000	0.995	0.005
T37.4 Anthelminthics	0.000	0.995	0.005
T37.3 Other antiprotozoal drugs	0.000	0.995	0.005
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.995	0.005
T37.1 Antimycobacterial drugs	0.000	0.995	0.005
T37.0 Sulphonamides	0.000	0.995	0.005
T41.5 Therapeutic gases	0.000	0.995	0.005
T41.4 Anaesthetic, unspecified	0.000	0.995	0.005
T41.3 Local anaesthetics	0.000	0.995	0.005
T41.2 Other and unspecified general anaesthetics	0.000	0.995	0.005
T41.1 Intravenous anaesthetics	0.000	0.995	0.005
T41.0 Inhaled anaesthetics	0.000	0.995	0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.995	0.005
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
T47.7 Emetics	0.000	0.995	0.005
T47.6 Antidiarrhoeal drugs	0.000	0.995	0.005
T47.5 Digestants	0.000	0.995	0.005
T47.4 Other laxatives	0.000	0.995	0.005
T47.3 Saline and osmotic laxatives	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.005
T47.0 Histamine H(2)-receptor antagonists	0.000	0.995	0.005
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.995	0.005
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.995	0.005
T48.5 Anti-common-cold drugs	0.000	0.995	0.005
T48.4 Expectorants	0.000	0.995	0.005
T48.3 Antitussives	0.000	0.995	0.005
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.995	0.005
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.995	0.005
T48.0 Oxytocic drugs	0.000	0.995	0.005
T49.9 Topical agent, unspecified	0.000	0.995	0.005
T49.8 Other topical agents	0.000	0.995	0.005
T49.7 Dental drugs, topically applied	0.000	0.995	0.005
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.995	0.005
T49.5 Ophthalmological drugs and preparations	0.000	0.995	0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.995	0.005
T49.3 Emollients, demulcents and protectants	0.000	0.995	0.005
T49.2 Local astringents and local detergents	0.000	0.995	0.005
T49.1 Antipruritics	0.000	0.995	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.005
H65.3 Chronic mucoid otitis media	0.005	0.995	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.995	0.005
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.995	0.005
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.995	0.005
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.995	0.005
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.995	0.005
T44.0 Anticholinesterase agents	0.000	0.995	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.995	0.005
T45.8 Other primarily systemic and haematological agents	0.000	0.995	0.005
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.995	0.005
T45.6 Fibrinolysis-affecting drugs	0.000	0.995	0.005
T45.5 Anticoagulants	0.000	0.995	0.005
T45.4 Iron and its compounds	0.000	0.995	0.005
T45.3 Enzymes, not elsewhere classified	0.000	0.995	0.005
T45.2 Vitamins, not elsewhere classified	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.995	0.005
H72.0 Central perforation of tympanic membrane	0.005	0.995	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.005	0.995	0.000
H70 Mastoiditis and related conditions	0.005	0.995	0.000
H68 Eustachian salpingitis and obstruction	0.005	0.995	0.000
H67 Otitis media in diseases classified elsewhere	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.005
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.995	0.005
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.995	0.005
T38.7 Androgens and anabolic congeners	0.000	0.995	0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.995	0.005
T38.5 Other oestrogens and progestogens	0.000	0.995	0.005
T38.4 Oral contraceptives	0.000	0.995	0.005
T38.2 Antithyroid drugs	0.000	0.995	0.005
T38.1 Thyroid hormones and substitutes	0.000	0.995	0.005
T38.0 Glucocorticoids and synthetic analogues	0.000	0.995	0.005
H69 Other disorders of Eustachian tube	0.005	0.995	0.000
G20-G26 Extrapyramidal and movement disorders	0.005	0.995	0.000
H66.9 Otitis media, unspecified	0.005	0.995	0.000
H74.2 Discontinuity and dislocation of ear ossicles	0.005	0.995	0.000
H74.1 Adhesive middle ear disease	0.005	0.995	0.000
C43 Malignant melanoma of skin	0.005	0.995	0.000
M54.50 Low back pain (Multiple sites in spine)	0.000	0.995	0.005
H74.0 Tympanosclerosis	0.005	0.995	0.000
H72.8 Other perforations of tympanic membrane	0.005	0.995	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.000	0.995	0.005
H74.8 Other specified disorders of middle ear and mastoid	0.005	0.995	0.000
M54.56 Low back pain (Lumbar region)	0.000	0.995	0.005
H65.1 Other acute nonsuppurative otitis media	0.004	0.995	0.000
H65.0 Acute serous otitis media	0.004	0.995	0.000
H72.2 Other marginal perforations of tympanic membrane	0.004	0.995	0.000
H72.1 Attic perforation of tympanic membrane	0.004	0.995	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
H65.2 Chronic serous otitis media	0.004	0.996	0.000
H66.3 Other chronic suppurative otitis media	0.004	0.996	0.000
H66.4 Suppurative otitis media, unspecified	0.004	0.996	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.004	0.996	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.004	0.996	0.000
H66.0 Acute suppurative otitis media	0.004	0.996	0.000
M54.55 Low back pain (Thoracolumbar region)	0.000	0.996	0.004
M54.54 Low back pain-Thoracic	0.000	0.996	0.004
M54.53 Low back pain-Cervicothoracic	0.000	0.996	0.004
M54.52 Low back pain-Cervical	0.000	0.996	0.004
M54.51 Low back pain-Occipit-atl-axl	0.000	0.996	0.004
H73 Other disorders of tympanic membrane	0.004	0.996	0.000
R04.0 Epistaxis	0.000	0.996	0.004
H65.4 Other chronic nonsuppurative otitis media	0.004	0.996	0.000
C43.9 Malignant melanoma of skin, unspecified	0.004	0.996	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.004	0.996	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.004	0.996	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.004	0.996	0.000
H68.1 Obstruction of Eustachian tube	0.004	0.996	0.000
H68.0 Eustachian salpingitis	0.004	0.996	0.000
H70.9 Mastoiditis, unspecified	0.004	0.996	0.000
H70.8 Other mastoiditis and related conditions	0.004	0.996	0.000
H70.2 Petrositis	0.004	0.996	0.000
H70.1 Chronic mastoiditis	0.004	0.996	0.000
H70.0 Acute mastoiditis	0.004	0.996	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.004	0.996	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.000	0.996	0.004
H69.8 Other specified disorders of Eustachian tube	0.004	0.996	0.000
H69.0 Patulous Eustachian tube	0.004	0.996	0.000
G23 Other degenerative diseases of basal ganglia	0.004	0.996	0.000
G21 Secondary Parkinsonism	0.004	0.996	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.004	0.996	0.000
G22 Parkinsonism in diseases classified elsewhere	0.004	0.996	0.000
C43.8 Overlapping malignant melanoma of skin	0.004	0.996	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.004	0.996	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.004	0.996	0.000
C43.0 Malignant melanoma of lip	0.004	0.996	0.000
H69.9 Eustachian tube disorder, unspecified	0.003	0.996	0.000
C43.4 Malignant melanoma of scalp and neck	0.004	0.996	0.000
C43.5 Malignant melanoma of trunk	0.004	0.996	0.000
Z60 Problems related to social environment	0.000	0.996	0.004
G24 Dystonia	0.003	0.997	0.000
C25.9 Pancreas, unspecified	0.000	0.997	0.003
C43.3 Malignant melanoma of other and unspecified parts of face	0.003	0.997	0.000
M54.57 Low back pain (Lumbosacral region)	0.000	0.997	0.003
G25 Other extrapyramidal and movement disorders	0.003	0.997	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.003	0.997	0.000
H73.1 Chronic myringitis	0.003	0.997	0.000
H73.0 Acute myringitis	0.003	0.997	0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.003	0.997	0.000
M54.1 Radiculopathy	0.000	0.997	0.003
M54 Dorsalgia	0.000	0.997	0.003
R10.3 Pain localised to other parts of lower abdomen	0.003	0.997	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.003	0.997	0.000
G21.9 Secondary Parkinsonism, unspecified	0.003	0.997	0.000
G21.8 Other secondary Parkinsonism	0.003	0.997	0.000
G21.4 Vascular parkinsonism	0.003	0.997	0.000
G21.3 Postencephalitic Parkinsonism	0.003	0.997	0.000
G21.2 Secondary Parkinsonism due to other external agents	0.003	0.997	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.003	0.997	0.000
G21.0 Malignant neuroleptic syndrome	0.003	0.997	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.003	0.997	0.000
G23.8 Other specified degenerative diseases of basal ganglia	0.003	0.997	0.000
G23.3 Multiple system atrophy, cerebellar type	0.003	0.997	0.000
G23.2 Striatonigral degeneration	0.003	0.997	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.003	0.997	0.000
G23.0 Hallervorden-Spatz disease	0.003	0.997	0.000
M54.16 Radiculopathy (Lumbar region)	0.000	0.997	0.003
M54.12 Radiculopathy (Cervical region)	0.000	0.997	0.003
K65.9 Peritonitis, unspecified	0.003	0.997	0.000
K65.0 Acute peritonitis	0.003	0.997	0.000
Z60.9 Problem related to social environment, unspecified	0.000	0.997	0.003
Z60.8 Other problems related to social environment	0.000	0.997	0.003
Z60.5 Target of perceived adverse discrimination and persecution	0.000	0.997	0.003
Z60.4 Social exclusion and rejection	0.000	0.997	0.003
Z60.3 Acculturation difficulty	0.000	0.997	0.003
Z60.1 Atypical parenting situation	0.000	0.997	0.003
Z60.0 Problems of adjustment to life-cycle transitions	0.000	0.997	0.003
M54.39 Sciatica (Site unspecified)	0.000	0.997	0.003
G25.3 Myoclonus	0.003	0.997	0.000
M54.3 Sciatica	0.000	0.997	0.003
G24.8 Other dystonia	0.003	0.997	0.000
G24.5 Blepharospasm	0.003	0.997	0.000
G24.4 Idiopathic orofacial dystonia	0.003	0.997	0.000
G24.3 Spasmodic torticollis	0.003	0.997	0.000
G24.2 Idiopathic nonfamilial dystonia	0.003	0.997	0.000
G24.1 Idiopathic familial dystonia	0.003	0.997	0.000
G24.0 Drug-induced dystonia	0.003	0.997	0.000
H52.1 Myopia	0.000	0.997	0.003
K65 Peritonitis	0.003	0.997	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.003	0.997	0.000
M54.4 Lumbago with sciatica	0.000	0.997	0.003
G25.9 Extrapyramidal and movement disorder, unspecified	0.002	0.997	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.002	0.997	0.000
G25.5 Other chorea	0.002	0.997	0.000
G25.4 Drug-induced chorea	0.002	0.997	0.000
G25.2 Other specified forms of tremor	0.002	0.997	0.000
G25.1 Drug-induced tremor	0.002	0.997	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.003	0.997	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.003	0.997	0.000
M54.19 Radiculopathy (Site unspecified)	0.000	0.997	0.002
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M54.17 Radiculopathy (Lumbosacral region)	0.000	0.997	0.002
M54.15 Radiculopathy (Thoracolumbar region)	0.000	0.997	0.002
M54.14 Radiculopathy (Thoracic region)	0.000	0.997	0.002
M54.13 Radiculopathy (Cervicothoracic region)	0.000	0.997	0.002
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.000	0.997	0.002
M54.10 Radiculopathy (Multiple sites in spine)	0.000	0.997	0.002
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.002	0.997	0.000
N73.6 Female pelvic peritoneal adhesions	0.000	0.997	0.003
J02.9 Acute pharyngitis, unspecified	0.000	0.997	0.003
M54.8 Other dorsalgia	0.000	0.997	0.002
M54.0 Panniculitis affecting regions of neck and back	0.000	0.997	0.002
M54.2 Cervicalgia	0.000	0.997	0.002
G24.9 Dystonia, unspecified	0.002	0.998	0.000
K66.0 Peritoneal adhesions	0.002	0.998	0.000
I51.8 Other ill-defined heart diseases	0.002	0.998	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.002	0.998	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.002	0.998	0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.002	0.998	0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.002	0.998	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.002	0.998	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.998	0.002
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.002	0.998	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.998	0.002
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.35 Sciatica (Thoracolumbar region)	0.000	0.998	0.002
M54.34 Sciatica-Thoracic	0.000	0.998	0.002
M54.33 Sciatica-Cervicothoracic	0.000	0.998	0.002
M54.32 Sciatica-Cervical	0.000	0.998	0.002
M54.31 Sciatica-Occipit-atl-axl	0.000	0.998	0.002
M54.30 Sciatica (Multiple sites in spine)	0.000	0.998	0.002
C67.9 Bladder, unspecified	0.002	0.998	0.000
H52.0 Hypermetropia	0.000	0.998	0.002
M54.6 Pain in thoracic spine	0.000	0.998	0.002
G25.0 Essential tremor	0.002	0.998	0.000
K65.8 Other peritonitis	0.002	0.998	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.002	0.998	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.998	0.002
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.47 Lumbago with sciatica (Lumbosacral region)	0.000	0.998	0.002
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.000	0.998	0.002
M54.44 Lumbago with sciatica-Thoracic	0.000	0.998	0.002
M54.43 Lumbago with sciatica-Cervicothoracic	0.000	0.998	0.002
M54.42 Lumbago with sciatica-Cervical	0.000	0.998	0.002
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.000	0.998	0.002
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.000	0.998	0.002
M54.37 Sciatica (Lumbosacral region)	0.000	0.998	0.002
H52 Disorders of refraction and accommodation	0.000	0.998	0.002
M84 Disorders of continuity of bone	0.002	0.998	0.000
K66 Other disorders of peritoneum	0.002	0.998	0.000
S52.60 Fracture of lower end of both ulna and radius (closed)	0.002	0.998	0.000
R03.1 Nonspecific low blood-pressure reading	0.000	0.998	0.002
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.000	0.998	0.002
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.000	0.998	0.002
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.000	0.998	0.002
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.000	0.998	0.002
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.000	0.998	0.002
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.000	0.998	0.002
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.000	0.998	0.002
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.000	0.998	0.002
M54.89 Other dorsalgia (Site unspecified)	0.000	0.998	0.002
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M54.87 Other dorsalgia (Lumbosacral region)	0.000	0.998	0.002
M54.86 Other dorsalgia (Lumbar region)	0.000	0.998	0.002
M54.85 Other dorsalgia (Thoracolumbar region)	0.000	0.998	0.002
M54.84 Other dorsalgia (Thoracic region)	0.000	0.998	0.002
M54.83 Other dorsalgia (Cervicothoracic region)	0.000	0.998	0.002
M54.82 Other dorsalgia (Cervical region)	0.000	0.998	0.002
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.80 Other dorsalgia (Multiple sites in spine)	0.000	0.998	0.002
I51.7 Cardiomegaly	0.002	0.998	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.998	0.002
M54.27 Cervicalgia-Lumbosacral	0.000	0.998	0.002
M54.26 Cervicalgia-Lumbar	0.000	0.998	0.002
M54.25 Cervicalgia-Thoracolumbar	0.000	0.998	0.002
M54.24 Cervicalgia-Thoracic	0.000	0.998	0.002
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.998	0.002
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.998	0.002
M54.20 Cervicalgia-Mult site	0.000	0.998	0.002
Z51.4 Preparatory care for treatment, not elsewhere classified	0.000	0.998	0.002
M84.0 Malunion of fracture	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.002	0.998	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
K41 Femoral hernia	0.002	0.998	0.000
C67.5 Bladder neck	0.002	0.998	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.998	0.002
R44.3 Hallucinations, unspecified	0.002	0.998	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations